About Kisspeptin Source.

What this site is

Kisspeptin Source is an independent editorial project that publishes summaries of the peer-reviewed research literature on Kisspeptin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The name reads kisspeptin as a single signal flaring out of darkness — one pulse fired by a small population of hypothalamic neurons, traced from where it begins. That is a position relative to the literature, an editorial stance, not a claim about services. 'Source' here means we read from the source — the published trials — and cite back to them. It does not mean we are a supplier.

How we read the record

This site reads kisspeptin through one lens: its pharmacokinetics by isoform — the brief bright flare of kisspeptin-10 and the longer burn of kisspeptin-54. Every quantitative claim is attributed to a named study and indexed on the references page. Where the evidence is genuine and reproducible — the LH rise in men, the restored cycles in amenorrhea, the IVF trigger with no severe over-stimulation — we say so plainly. Where it is thin or unsettled — long-term safety, the sparse consumer record, the rodent vascular signal — we leave the gap openly unfilled rather than paper over it.

We hold two facts in plain sight on every page: kisspeptin is investigational, approved by no regulator for any indication, and it is not a dietary supplement despite the search term. We render doses only as research protocols, attributed to a population and route, never as instructions.

What we are not

The 'source' in our name is editorial framing, not a service offering. We are a publisher of research digests, not a healthcare provider, not a pharmacy, and not a research-chemical vendor. We do not consult, prescribe, compound, or sell. The sensitive human reports we summarize — sexual desire, fertility, mood — appear only as clearly labeled anecdote, kept apart from the cited trial data, with no doses attached and no claim that they are proven outcomes.